首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献，搜索用时 547 毫秒
1.
Streptococcus agalactiae is an emerging pathogen of fish and has caused significant morbidity and mortality worldwide. The main objective of this study is to assess whether pathogenic differences exist among isolates from different geographic locations. Nile tilapia (Oreochromis niloticus L.) were administered an intraperitoneal injection of suspension containing USA, Brazil, Honduras, Israel, or Kuwait S. agalactiae isolates at concentrations ranging from 102 to 107 cfu mL?1. The LD50 values 7 days after challenge were as follows: USA (1.0 × 102 cfu mL?1), Brazil (1.5 × 103 cfu mL?1), Honduras (6.8 × 103 cfu mL?1), Israel (1.0 × 104 cfu mL?1) and Kuwait (7.2 × 105 cfu mL?1). Fish from all groups exhibited lethargy, anorexia, exophthalmia, corneal opacity, erratic swimming, petechiae and mortality. Opercular clearing and ascites were only found after infection with certain geographic isolates. The findings in this study indicate that S. agalactiae isolates of different geographic origin can cause significant mortalities after experimental challenge and can have different pathogenic capacities. Isolates from the Americas (USA, Brazil and Honduras) were more pathogenic to Nile tilapia than isolates from the Middle East/Asia (Israel and Kuwait).  相似文献   

2.
Streptococcus agalactiae is an important pathogen in fish, causing great losses of intensive tilapia farming. To develop a potential live attenuated vaccine, a re‐attenuated S. agalactiae (named TFJ‐ery) was developed from a natural low‐virulence S. agalactiae strain TFJ0901 through selection of resistance to erythromycin. The biological characteristics, virulence, stability and the immunization protective efficacy to tilapia of TFJ‐ery were determined. The results indicated that TFJ‐ery grew at a slower rate than TFJ0901. The capsule thickness of TFJ‐ery was significantly less (p < 0.05) than TFJ0901. When Nile tilapia were intraperitoneally (IP) injected with TFJ‐ery, the mortality of fish was decreased than that injected with TFJ0901. The RPS of fish immunized with TFJ‐ery at a dose of 5.0 × 107 CFU was 95.00%, 93.02% and 100.00% at 4, 8 and 16 weeks post‐vaccination, respectively. ELISA results showed that the vaccinated fish produced significantly higher (p < 0.05) antibody titres compared to those of control at 2 or 4 weeks post‐vaccination. Taken together, our results suggest that erythromycin could be used to attenuate S. agalactiae, and TFJ‐ery is a potent attenuated vaccine candidate to protect tilapia against S. agalactiae infections.  相似文献   

3.
This study was conducted to quantify and characterize the mycoflora associated with the ‘green water’ culture system of Penaeus monodon. Samples of water, tilapia gut and mucus, and shrimp hepatopancreas from three shrimp farms were collected during 15, 30, 45 and 60 days of culture (DOC). Results showed that high fungal loads were observed in tilapia gut (total: 117–1352 colony forming unit (CFU) 5 cm hind gut?1; yeasts: 0–136 CFU 5 cm hind gut?1) and mucus (total: 12–311 CFU (5 cm2)?1; yeasts: 0–88 CFU (5 cm2)?1), while minimal fungal populations were observed in water samples (total: 0–110CFU mL?1; yeasts: 0–5 CFU ml?1). Shrimp hepatopancreas harboured a very low number of filamentous fungi (0–27 CFU 0.1 g?1) and yeasts (0–7CFU 0.1 g?1) especially at 60 DOC. The filamentous fungal isolates were dominated by Penicillium and Aspergillus species, while the yeast populations were dominated by Rhodotorula and Saccharomyces species. The dominance of these fungi on tilapia mucus and gut and their presence in the rearing water might play an important role in the overall mechanisms involved in the control of luminous Vibrio in the ‘green water’ grow‐out culture of P. monodon.  相似文献   

4.
Abstract

β-hydroxy-b-methylbutyrate (HMB), a leucine catabolite, has been shown to cause increased disease resistance and growth in animal production. A vaccine produced from formalin killed bacteria and concentrated extracellular products of the ARS-98-60 Streptococcus iniae isolate has been used for the prevention of streptococcal disease in Nile tilapia, Oreochromis niloticus. In the present study, the effects of feeding HMB were determined in tilapia vaccinated by intraperitoneal (IP) injection of the S. iniaevaccine or unvaccinated (controls). Nile tilapia were fed diets containing either 0, 12.5, 25, or 50 mg HMB/kg diet for 14 days. The mean daily growth rate and feed efficiency showed no significant (P> 0.05) differences between the treatment groups. Dietary HMB supplementation did not enhance antibody production in unvacci-nated Nile tilapia following challenge. Dietary HMB supplementation did not enhance the survival of vaccinated Nile tilapia following challenge injection with 1 X108 CFU of S. iniae.  相似文献   

5.
We evaluated the effects of Bacillus cereus, as an additive in water and feed, on the gut microbiota and immunological parameters of Nile tilapia (Oreochromis niloticus) fingerlings. Experiments were performed in tanks and net cages respectively. Experiment 1: Tilapia were housed in tanks for 42 days, and B. cereus was added to the water at 1.0 × 104 cfu mL?1 (Treatment 1) and 1.0 ×105 cfu mL?1 (Treatment 2) weekly. For the control, no probiotic was added. Experiment 2: Tilapia were housed in cages for 42 days, and the feed was supplemented with B. cereus at 1.0 × 107 cfu g?1 (Treatment 1) and 1.0 × 108 cfu g?1 (Treatment 2) weekly. For the control, no probiotic was added. Each treatment contained three replicates, with 50 male tilapias per replicate. The fish from the probiotic treatments in both tank and cage experiments had significantly higher serum lysozyme and peroxidase activities than the control. In the cage experiment, alkaline phosphatase and total superoxide dismutase activities in tilapia were significantly higher in probiotic treatments compared with the control. The results of polymerase chain reaction‐denaturing gradient gel electrophoresis showed that B. cereus supplementation in the feed and water affected the autochthonous gut bacteria community of tilapia and stimulated various potentially beneficial bacteria. Therefore, B. cereus, as a water or feed additive, could enhance the immune status and affect the gut microbiota of tilapia. Bacillus cereus was more effective as a feed supplement rather than a water additive for enhancing the immune status of tilapia.  相似文献   

6.
Aquaflor® [50% w w?1 florfenicol (FFC)], is approved for use in freshwater‐reared warmwater finfish which include tilapia Oreochromis spp. in the United States to control mortality from Streptococcus iniae. The depletion of florfenicol amine (FFA), the marker residue of FFC, was evaluated after feeding FFC‐medicated feed to deliver a nominal 20 mg FFC kg?1 BW d?1 dose (1.33× the label use of 15 mg FFC kg?1 BW d?1) to Nile tilapia O. niloticus and hybrid tilapia O. niloticus × O. aureus held in a recirculating aquaculture system (RAS) at production‐scale holding densities. Florfenicol amine concentrations were determined in fillets taken from 10 fish before dosing and from 20 fish at nine time points after dosing (from 1 to 240 h post‐dosing). Water samples were assayed for FFC before, during and after the dosing period. Parameters monitored included daily feed consumption and biofilter function (levels of ammonia, nitrite and nitrate). Mean fillet FFA concentration decreased from 13.77 μg g?1 at 1‐h post dosing to 0.39 μg g?1 at 240‐h post dosing. Water FFC concentration decreased from a maximum of 1400 ng mL?1 at 1 day post‐dosing to 847 ng mL?1 at 240 h post‐dosing. There were no adverse effects noted on fish, feed consumption or biofilter function associated with FFC‐medicated feed administration to tilapia.  相似文献   

7.
Francisella noatunensis subsp. orientalis is a pathogen of tilapia and other warm‐water fish for which no vaccines are commercially available. In this study, a whole cell formalin‐inactivated vaccine was developed for the first time using the highly virulent isolate STIR‐GUS‐F2f7 and the oil‐based adjuvant Montanide? ISA 763A VG. The efficacy of the vaccine was assessed in red Nile tilapia via intraperitoneal (i.p.) injection using homologous experimental infection and correlates of protection such as seral antibody production and bacterial loads in the spleen. For immunization, fish were i.p. injected with 0.1 ml of the vaccine, the adjuvant alone or PBS. At 840 degree days post‐vaccination, all fish were i.p. injected with 4.0 × 103 CFU/fish of pathogenic bacteria. The RPS at the end of the trial was 100% in the vaccinated group with significantly higher survival than in the adjuvant and control groups. The RPS in the adjuvant group was 42%, and no significant difference was seen in survival between this and the PBS group. Moreover, significantly higher antibody titres in the serum and significantly lower bacterial loads in the spleen were detected in the vaccinated fish by ELISA and qPCR, respectively. These findings highlight the potential of autogenous vaccines for controlling francisellosis in tilapia.  相似文献   

8.
刘灵  徐俊  马盼  李安兴 《水产学报》2019,43(5):1308-1316
实验采用BALB/c小鼠作为实验动物,旨在建立尼罗罗非鱼无乳链球菌毒力测定的BALB/c小鼠模型。BALB/c小鼠经腹腔注射尼罗罗非鱼源无乳链球菌建立感染模型,比较了尼罗罗非鱼源无乳链球菌分别感染尼罗罗非鱼和小鼠的LD_(50)差异,分别测定了不同毒力尼罗罗非鱼无乳链球菌对尼罗罗非鱼和小鼠的毒力。结果显示,小鼠经腹腔注射无乳链球菌,在24 h内出现死亡现象,且对小鼠脑、肝脏、脾脏、肾脏等组织造成损伤。3次测定尼罗罗非鱼无乳链球菌TFJ0901对尼罗罗非鱼和小鼠LD_(50)分别为7.7×10~7、2.2×10~8、3.5×10~9 CFU/mL和405、361、419 CFU/只。将无乳链球菌TFJ0901和THN0901感染尼罗罗非鱼(1.0×10~7 CFU/mL)和小鼠(100 CFU/只),尼罗罗非鱼和小鼠存活率分别为100%、6.7%±5.8%和100%、0,其存活率都具有显著性差异。将无乳链球菌TFJ0901和TFJ-F感染尼罗罗非鱼(3.0×10~8 CFU/mL)和小鼠(2 500 CFU/只),尼罗罗非鱼的存活率分别为73.3%±11.5%和80.0%±10.0%,存活率差异不显著,小鼠存活率分别为13.3%±11.5%和100.0%,存活率具有显著性差异。研究表明,本实验成功建立了BALB/c小鼠作为尼罗罗非鱼源无乳链球菌毒力测定的稳定模型,测定不同毒力的尼罗罗非鱼源无乳链球菌对小鼠毒力与对尼罗罗非鱼毒力一致,且该模型能够区分尼罗罗非鱼模型难以区分的毒力相近的无乳链球菌。  相似文献   

9.
An eight-week trial was performed to evaluate three commercial/prototype probiotics supplemented in red hybrid tilapia, Oreochromis sp. diets. Triplicate groups of tilapia were measured for growth performance, feeding efficiencies, and whole-body composition. After the feeding trial, duplicate groups of tilapia were assessed for their resistance to Streptococcus agalactiae over 23 days. Six diets were supplemented with 0.1% or 0.3% PB1 consisting of Bacillus subtilis, 0.1% or 0.3% PB2 consisting of B. licheniformis or 0.1% MPB consisting of Bacillus sp. and Pediococcus sp. Probiotics had no effect (p > 0.05) on growth or feeding efficiencies, although whole-body crude protein was significantly higher in the PB1 0.3% treatment. Tilapia in the probiotic treatments had a higher resistance to S. agalactiae and, with the exception of the PB2 0.1% diet, were all significantly higher than the control treatment. Although the tested probiotics were not growth promoters, dietary B. subtilis was the most effective prophylactic against pathogenic bacteria.  相似文献   

10.
The present study evaluated the effects of inclusion of glycerol in the diet of Nile tilapia juveniles on growth performance, biochemical changes in blood, and carcass composition. We used 300 Nile tilapia juveniles with an average initial weight of 29.15 ± 8.40 g and 11.55 ± 0.87 cm in length, distributed in 20 fiberglass tanks with a capacity of 250 L. The experiments followed a completely randomized design with five treatments and four replications during 79 days. The animals were fed diets containing four concentrations of glycerol (25 g kg?1, 50 g kg?1, 75 g kg?1 and 100 g kg?1) and a control diet without glycerol. HDL was the only biochemical parameter, that showed statistically different (P < 0.05) results; it was higher in the groups fed with 0 and 75 g kg?1 glycerol compared to the other groups. No significant difference was observed in the results from the carcass composition of tilapia juvenile fed with the different glycerol levels, except for lipids (P < 0.05), which showed the highest values in fish fed with 50 g kg?1 glycerol and the lowest in fish fed with 100 g kg?1. Glycerol can be used in fish diets as an energy supplement without causing damage to growth performance or to the biochemical and carcass composition of Nile Tilapia juveniles.  相似文献   

11.
This study aims to evaluate the efficacy of Streptococcus agalactiae vaccine preparations, administered to tilapia broodstock, in preventing streptococcosis, through specific and non-specific immunity being transferred to the offspring. The study was conducted in two phases. The first was the vaccination of the broodstock using a whole-cell vaccine, an extracellular product (ECP) vaccine, and a combination of the two with a ratio of 1:1. The vaccines were administered to the broodstock 2 and 3 weeks before spawning. The second phase was the challenge test for larvae produced by vaccinated broodstock, and larvae from the unvaccinated control broodstock, through immersion in a suspension of 107 cfu mL?1 pathogenic S. agalactiae for 30 min, at ages 7, 14, 21, and 28 days post-hatching. The parameters evaluated were the broodstock’s blood profile, antibody-lysozyme (in broodstock, eggs, and larvae), and the larvae’s relative percent survival. Treatment with the combined vaccine administered 3 weeks before spawning resulted in the broodstock having significantly better antibody levels, lysozyme activity, and hematology profiles, compared to the other treatments (p?<?0.05). In addition, the larvae produced by broodstock subjected to this treatment, when challenged with the pathogenic S. agalactiae at ages 7, 14, 21, and 28 days, had RPS values of 95.24, 83.33, 72.22, and 56.02%, respectively. It was concluded that the administration of the “whole-cell/ECP” combination vaccine preparation to tilapia broodstock in the 3 weeks before spawning can increase specific and non-specific immunity in the broodstock and protect the larvae from S. agalactiae infection.  相似文献   

12.
This study was conducted to determine the systemic, mucosal immunity and protective capacity of the feed‐based adjuvant vaccine (FAV) of Streptococcus agalactiae following oral vaccination against streptococcosis in tilapias. Two hundred and sixteen red tilapia fish were divided into three major groups. Each major group consisted eight tilapia kept in nine 2000 L glass aquaria. At day 0, all fish from the FAV group were fed with feed that had been incorporated with an adjuvant, while fish in the feed‐based vaccine (FNV) group were fed with vaccine incorporated into the pellet without adjuvant. Fish in the control‐unvaccinated group, FC, were fed with normal commercial pellet. Booster dose was performed on day 14 post immunization. Fish from each group were sacrificed on a weekly basis for the entire 7 weeks. Serum, body mucus and gut lavage fluid were evaluated for antibody responses by indirect ELISA, while histological examination was carried out on the gut following intraperitoneal challenge. The FAV group had a significantly higher protection (P < 0.05) following challenge with 3.4 × 109 CFU mL?1 of live S. agalactiae than FNV group. This level of protection may be due to high antibody responses, increase in size of gut‐associated lymphoid tissue and high number of lymphocytes in the FAV group.  相似文献   

13.
Koi herpesvirus specifically infects and causes mass mortality on koi and carp, resulting in severe economic losses. In this study, we presented the efficacy of KHV DNA vaccine administration by immersion method on Cyprinus carpio. Two different immersion densities of fish were applied, namely 800 fish L?1 and 1200 fish L?1. Thirty‐day‐old common carp juveniles were immersed for 30 min in the water containing 1.3 × 108 CFU mL?1 of heat‐killed Escherichia coli carrying DNA vaccine encoding glycoprotein‐25, and without vaccination treatment as controls. The challenge test was performed at 30 days post vaccination by injecting 0.1 mL KHV filtrate (10?3 of dilution rate). The result showed that higher relative per cent survival of KHV‐challenged fish was obtained in 800 fish L?1 (P < 0.05). Furthermore, significant specific antibody anti‐KHV response (P < 0.05) was detected on 28 and 36 days post vaccination in 800 and 1200 fish L?1, respectively, compared to the controls there was no specific antibody detected. In conclusion, the KHV DNA vaccine could provide good protection in common carp against KHV infection, which has practical applications in aquaculture practices.  相似文献   

14.
Flavobacterium columnare is a bacterial pathogen for many freshwater fish species. It is responsible for outbreaks in fish farms worldwide, causing high mortality rates. Fish vaccination is a potential approach for prevention and control of disease, with oral vaccines suitable for fish because of their easier application, low cost and minimum stress to fish. Alginate microparticles have been widely used as controlled release systems, including for fish vaccination. The aim of this study was to evaluate the capacity of oral and parenteral vaccines against F. columnare to induce a humoral response, as well as the in vivo efficiency in Nile tilapia fingerlings. The fingerlings were immunized with bacterin by intraperitoneal (i.p.), intramuscular (i.m.), oral and immersion routes, as well as orally with alginate microparticles containing formalin-killed bacteria. A sandwich ELISA was developed to detect specific antibodies against F. columnare. The animals were challenged with pathogenic strain BZ-1 to determine the relative percentage of survival. A significant humoral response was induced by bacterin administered by i.p. and i.m. routes (P < 0.05). However, none of the vaccine preparations were effective in protecting fish against F. columnare infection (P < 0.05). In spite of high antibody levels, there was no relation between immunoglobulin titers and resistance to columnaris for Nile tilapia fingerlings. These data suggest that use of serological analysis as the only method to determine vaccine efficiency against F. columnare infection in Nile tilapia can lead to imprecise results for the usefulness of these products in vivo.  相似文献   

15.
Effect of salinity on carrying capacity of a recirculation system for Nile tilapia, Oreochromis niloticus L.; production was assessed. Survival, growth and feed conversion ratio of adult Nile tilapia fed 30% crude protein diet for 88 days were measured at three different salinity levels (8, 15 and 25 g L?1) and two stocking densities (20 and 40 m?3) in three independent recirculating systems. Highest survival (98%) and a linear growth in net biomass (P<0.01) was observed in both densities at 8 g L?1 and in 20 m?3 treatment at 15 g L?1. Highest net biomass growth was observed in the 40 m?3 stocking density treatment at 8 g L?1 salinity level (P<0.05). Overall biomass growth was significantly affected by salinity indicating a decrease in Nile tilapia carrying capacity with increased salinity. About 11 000 kg ha?1 crop?1 of Nile tilapia can be obtained in recirculating systems at 8 g L?1 salinity, significantly higher than the net production at 15 g L?1 (5200 kg ha?1 crop?1) and 22 g L?1 (4425 kg ha?1 crop?1).  相似文献   

16.
朱佳杰  沈夏霜  付强  陈明  周宇  谭芸  甘西 《水产学报》2013,37(12):1821-1828
为研究罗非鱼感染无乳链球菌前后肝脏组织蛋白质的表达变化。本研究以吉富罗非鱼为材料,采用双向电泳技术分析其在无乳链球菌感染胁迫下24 h、48-144 h、12 d与对照组（未感染）肝脏组织蛋白质组的变化,对差异表达蛋白进行质谱分析鉴定。结果显示：吉富罗非鱼在无乳链球菌胁迫下,3个实验组的蛋白质图谱与对照组相比存在显著差异,共有30个蛋白点发生显著改变,其中13个表达上调,17个下调,2个下调蛋白点在感染12 d组消失。通过MALDI-TOF-MS MS/MS质谱分析和数据库检索对这些蛋白质进行了功能分类,发现它们涉及到能量代谢、细胞防御与应激、消化免疫、抗氧化与排毒等许多方面。推测这些蛋白可能在吉富罗非鱼对无乳链球菌胁迫的抗性反应中发挥了重要作用。研究结果为无乳链球菌疫苗的研制及吉富罗非鱼抗病品种选育奠定了基础。  相似文献   

17.
Francisella noatunensis subsp. orientalis (Fno) (syn. F. asiatica) is an emergent Gram‐negative facultative intracellular bacterium. Although it is considered one of the most pathogenic bacteria in fish, there are no commercially available treatments or vaccines. The objective of this project was to determine the most efficacious concentration of florfenicol (FFC) [10, 15 or 20 mg FFC kg?1 body weight (bw) per days for 10 days] administered in feed to control experimentally induced infections of Fno in Nile tilapia, Oreochromis niloticus (L.), reared in a recirculating aquaculture system. The cumulative mortality of fish that received 0, 10, 15 or 20 mg FFC kg?1 bw per day was 60, 37, 14 and 16%, respectively. Francisella noatunensis subsp. orientalis genome equivalents were detected in water from all challenged groups with slight reduction in the concentration in the florfenicol‐treated groups 4 days after treatment. The mean LOG of CFU Fno mg?1 spleen was 3–5 and was present in all challenged groups at necropsy 11 days after treatment (21 days after challenge). Results show that florfenicol administered at doses of 15 and 20 mg FFC kg?1 bw per days for 10 days significantly reduced mortality associated with francisellosis in Nile tilapia.  相似文献   

18.
This study aimed to examine the use of Streptococcus agalactiae polyvalent vaccine in tilapia broodstock and the effect of maternal immunity and resistance on their offspring against S. agalactiae strain. The broodstock was injected with polyvalent vaccine of S. agalactiae at a dose of 108 CFU per fish at 2nd gonadal maturity until spawning. Challenge test was carried out on the offspring at the 5, 10, 15 and 20 days after hatching using NK1, N17O, N14G, N3M, N4M strain respectively and combination of them. We observed immunological parameters in broodstock, eggs and larvae and relative per cent survival (RPS) of larvae after challenged with pathogenic S. agalactiae. The results showed that the leukocytes, phagocytic activity, respiratory burst, lysozyme activity and antibody levels of vaccinated broodstock had higher level compared with unvaccinated broodstock. The high level of the lysozyme activity, antibody levels and recombination activating gene 1 (RAG1) were also observed in eggs and larvae from vaccinated broodstock. Larvae produced from vaccinated broodstock when challenged with variety strain of pathogenic S. agalactiae had RPS value more than 50% until 20 days after hatching. In conclusion, polyvalent vaccine of S. agalactiae administrated in the broodstock could enhance immunity in the broodstock and protect their offspring from pathogenic S. agalactiae.  相似文献   

19.
无乳链球菌感染尼罗罗非鱼的脑膜炎模型   总被引：2，自引：2，他引：0  
目的：脑膜炎是罗非鱼无乳链球菌病的特征性临床症状,建立罗非鱼无乳链球菌脑膜炎模型,并制定相应的临床症状及组织病理学评分系统,对研究罗非鱼无乳链球菌病的致病机制具有十分重要的意义。方法：将健康罗非鱼43尾,随机分为4组：对照组(n=10)和试验组(n=33)。3组试验组根据不同感染剂量分为：106cfu组(n=11)、107cfu组(n=11)、108cfu组(n=11)。试验组分别将106、107、108CFU的无乳链球菌菌液腹腔注射罗非鱼复制脑膜炎模型。对感染罗非鱼的临床症状、剖检病变、脑组织(端脑、中脑、小脑、延脑)病理学进行判定,并结合细菌学检测,按照拟定的评分系统评价各组脑膜炎的造模效果,确定最佳造模方案。结果：各试验攻毒组罗非鱼感染后2天均出现不同程度死亡,未见明显神经症状。感染3天后鱼体开始出现异常活动的神经症状及突眼、角膜混浊等病理变化。病理组织学观察可见：蛛网膜下腔和脑软膜上有大量炎性渗出和染成蓝紫色微细颗粒的细菌团块,脑膜充血、水肿、疏松、增厚,有大量的中性白细胞等炎性细胞浸润;脑实质基质疏松水肿,呈海绵状;脑组织炎性细胞浸润,胶质细胞增生等软脑膜炎、脑膜脑炎症状。比较各组得分发现,107CFU组的无乳链球菌攻毒罗非鱼造模效果最好：临床症状显著而组内罗非鱼差异性最小,组织病理学观察患病罗非鱼病情和缓适中、利于观察研究。结论：使用107CFU无乳链球菌腹腔攻毒罗非鱼可在第3天成功构建脑膜炎模型,造模率为100%。  相似文献   

20.
Streptococcosis, lactococcosis and enterococcosis are among the most important bacterial diseases affecting tilapia farms in Kafr Elsheikh governorate, Egypt. A number of clinically diseased fish were collected and submitted to our laboratory during disease outbreak in 2018. They were characterized by nervous swimming behaviour, skin darkness, exophthalmia, ocular opacity and haemorrhages. Necropsy findings were splenomegaly, congestive hepatomegaly, liquefied brain and enteritis. The phenotypic and molecular characterizations of the bacterial strains isolated from naturally infected fish identified three genera of Gram‐positive cocci: Streptococcus agalactiae, Enterococcus faecalis and Lactococcus garvieae. Infectivity trials were conducted in four groups of Nile tilapia inoculated with S. agalactiae Egy‐1, E. faecalis Egy‐1 and L. garvieae Egy‐1 strains and saline. Mortalities, clinical signs and pathological findings were recorded daily 14 days post infection. Experimentally infected tilapia showed similar clinical signs, postmortem lesions, but varied in the severity and experienced high mortalities up to 70% in case of S. agalactiae and L. garvieae infections and 30% in case of E. faecalis infection. Pathological examination of infected tissue sections stained with modified Brown–Brenn and immunohistochemistry revealed an important direct correlation between the distribution of each bacterial isolate and the lesions developed in different organs. Furthermore, the isolates were subjected to profiling against 11 antibiotics, and they showed resistance against several types of antibiotics, which implicate potential risk to human health and emphasize the urgent need for alternate bio‐control strategies to prevent the diseases and the problem of multidrug resistance in aquatic environment.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号